These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 2900765

  • 1. 8-Bromo cyclic GMP mimics the actions of nitroglycerin in modulating responses produced by full and partial alpha-adrenoceptor agonists in canine saphenous vein.
    Eskinder H, Gross GJ.
    Eur Heart J; 1988 Jan; 9 Suppl A():11-5. PubMed ID: 2900765
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Alpha adrenoceptor subtypes and receptor reserve in human versus canine saphenous vein: sensitivity to blockade by nitroglycerin.
    Eskinder H, Hillard CJ, Olinger GN, Christensen CW, Baker JE, Warltier DC, Gross GJ.
    J Pharmacol Exp Ther; 1988 Dec; 247(3):941-8. PubMed ID: 2905005
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Relationship between alpha 2-adrenoceptor occupancy and response for B-HT 933 in canine saphenous vein.
    Ruffolo RR, Zeid RL.
    Eur J Pharmacol; 1985 May 08; 111(2):267-71. PubMed ID: 2862046
    [Abstract] [Full Text] [Related]

  • 7. Relationship between alpha adrenoceptor occupancy and response for the alpha-1 adrenoceptor agonist, cirazoline, and the alpha-2 adrenoceptor agonist, B-HT 933, in canine saphenous vein.
    Ruffolo RR, Zeid RL.
    J Pharmacol Exp Ther; 1985 Dec 08; 235(3):636-43. PubMed ID: 2867204
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An in vitro quantitative analysis of the alpha adrenoceptor partial agonist activity of dobutamine and its relevance to inotropic selectivity.
    Kenakin TP.
    J Pharmacol Exp Ther; 1981 Feb 08; 216(2):210-9. PubMed ID: 6109772
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance.
    Andrews KL, Lumsden NG, Farry J, Jefferis AM, Kemp-Harper BK, Chin-Dusting JP.
    Clin Sci (Lond); 2015 Jul 08; 129(2):179-87. PubMed ID: 25728899
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
    Ebihara Y, Karmazyn M.
    Cardiovasc Res; 1996 Sep 08; 32(3):622-9. PubMed ID: 8881523
    [Abstract] [Full Text] [Related]

  • 16. Nimodipine and inhibition of alpha adrenergic activation of the isolated canine saphenous vein.
    Cooke JP, Rimele TJ, Flavahan NA, Vanhoutte PM.
    J Pharmacol Exp Ther; 1985 Sep 08; 234(3):598-602. PubMed ID: 2863368
    [Abstract] [Full Text] [Related]

  • 17. Role of PKC in the attenuation of the cGMP-mediated relaxation of skinned resistance artery smooth muscle seen in glyceryl-trinitrate-tolerant rabbit.
    Nakano Y, Kusama N, Kajikuri J, Suzuki Y, Kanmura Y, Itoh T.
    Br J Pharmacol; 2004 Feb 08; 141(3):391-8. PubMed ID: 14718264
    [Abstract] [Full Text] [Related]

  • 18. Evidence for heterogeneity of prejunctional alpha-2-adrenoceptors.
    Oriowo MA, Hieble JP, Ruffolo RR.
    Pharmacology; 1991 Feb 08; 43(1):1-13. PubMed ID: 1683709
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Halothane selectively attenuates alpha 2-adrenoceptor mediated vasoconstriction, in vivo and in vitro.
    Larach DR, Schuler HG, Derr JA, Larach MG, Hensley FA, Zelis R.
    Anesthesiology; 1987 Jun 08; 66(6):781-91. PubMed ID: 2884899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.